Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Short Interest Down 85.1% in June

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 150,494 shares, a drop of 85.1% from the June 15th total of 1,009,848 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 1,428,492 shares, the days-to-cover ratio is presently 0.1 days.

Reckitt Benckiser Group Trading Up 0.7%

Shares of RBGLY stock traded up $0.09 on Friday, hitting $13.56. 303,890 shares of the stock traded hands, compared to its average volume of 715,378. The company has a quick ratio of 0.63, a current ratio of 0.85 and a debt-to-equity ratio of 0.98. Reckitt Benckiser Group has a 52 week low of $12.02 and a 52 week high of $17.80. The firm has a 50 day simple moving average of $12.77 and a two-hundred day simple moving average of $14.54.

Analysts Set New Price Targets

Several equities research analysts have recently commented on RBGLY shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. Morgan Stanley raised Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a report on Monday, March 16th. Kepler Capital Markets raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Finally, Zacks Research raised Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Monday, June 15th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.